Atara Biotherapeutics Inc (ATRA): Next-Year EPS Estimate 265.44%
As of 2026-11-12, Atara Biotherapeutics Inc (ATRA) has a next-year EPS growth estimate of 265.44%. Featured in our EPS revision report on 2026-09-08.
On 2026-11-11, analyst consensus for ATRA's next-year EPS growth shifted from 236.15% to 265.44% — a positive change of 29.29 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at -123.02%.
What's Driving This
ATRA’s rise is primarily tied to the sharp upward revision in next-year EPS growth estimates, from 156.43% to 236.15
Generated 2026-11-03 from news as of 2026-11-03
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 265.44%
- EPS growth this year
- -123.02%
- EPS next quarter (est)
- -$0.09
- Last price
- $7.93
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 265.44% | -123.02% | -$0.09 | $7.93 |
| 2026-11-11 | 265.44% | -123.02% | -$0.09 | $8.23 |
| 2026-11-10 | 236.15% | -126.90% | -$0.13 | $8.10 |
| 2026-11-09 | 236.15% | -126.90% | -$0.13 | $8.18 |
| 2026-11-07 | 236.15% | -126.90% | -$0.13 | $7.87 |
| 2026-11-06 | 236.15% | -126.90% | -$0.13 | $7.87 |
| 2026-11-05 | 236.15% | -126.90% | -$0.13 | $7.96 |
| 2026-11-04 | 236.15% | -126.90% | -$0.13 | $8.37 |
| 2026-11-03 | 236.15% | -126.90% | -$0.13 | $8.20 |
| 2026-11-02 | 236.15% | -126.90% | -$0.13 | $8.48 |
| 2026-10-31 | 236.15% | -126.90% | -$0.13 | $8.01 |
| 2026-10-30 | 236.15% | -126.90% | -$0.13 | $8.01 |
| 2026-10-29 | 236.15% | -126.90% | -$0.13 | $8.53 |
| 2026-10-28 | 236.15% | -126.90% | -$0.13 | $8.66 |
| 2026-10-27 | 236.15% | -126.90% | -$0.13 | $8.30 |
| 2026-10-26 | 236.15% | -126.90% | -$0.13 | $8.35 |
| 2026-10-23 | 236.15% | -126.90% | -$0.13 | $8.59 |
| 2026-10-22 | 236.15% | -126.90% | -$0.13 | $9.43 |
| 2026-10-21 | 236.15% | -126.90% | -$0.13 | $9.35 |
| 2026-10-20 | 236.15% | -126.90% | -$0.13 | $9.16 |
| 2026-10-19 | 236.15% | -126.90% | -$0.13 | $8.96 |
| 2026-10-16 | 236.15% | -126.90% | -$0.13 | $9.18 |
| 2026-10-15 | 236.15% | -126.90% | -$0.13 | $9.65 |
| 2026-10-14 | 236.15% | -126.90% | -$0.13 | $9.56 |
| 2026-10-13 | 236.15% | -126.90% | -$0.13 | $9.31 |
| 2026-10-12 | 236.15% | -126.90% | -$0.13 | $9.38 |
| 2026-10-11 | 236.15% | -126.90% | -$0.13 | $9.48 |
| 2026-10-10 | 236.15% | -126.90% | -$0.13 | $9.48 |
| 2026-10-09 | 236.15% | -126.90% | -$0.13 | $9.48 |
| 2026-10-08 | 236.15% | -126.90% | -$0.13 | $9.23 |
Reports Featuring ATRA
Recent News
- Atara Biotherapeutics: Q3 Earnings SnapshotAssociated Press
- Atara Biotherapeutics Announces Third Quarter 2026 Financial Results and Operational ProgressBusiness Wire
- Atara Biotherapeutics: Q1 Earnings SnapshotAssociated Press
- Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational ProgressBusiness Wire
- FDA Resubmission Path for Tab-cel Keeps Ataras (ATRA) Regulatory Timeline AliveInvestorsHub
- FDA Resubmission Path for Tab-cel Keeps Ataras (ATRA) Regulatory Timeline AliveInvestorsHub
- BC-Most Active StocksAssociated Press
- Atara Biotherapeutics Provides Regulatory Update on TabelecleucelBusiness Wire
- Atara Biotherapeutics Provides Regulatory Update on TabelecleucelBusiness Wire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Atara Biotherapeutics Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Atara Biotherapeutics Inc (ATRA) has a next-year EPS growth estimate of 265.44%, based on analyst consensus.
When was the latest EPS estimate revision for ATRA?▾
The most recent revision occurred on 2026-11-11, when analysts adjusted the next-year EPS growth estimate from 236.15% to 265.44%.
What sector and industry does Atara Biotherapeutics Inc belong to?▾
Atara Biotherapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ATRA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Atara Biotherapeutics Inc (ATRA) appears here because it was detected by our daily top-EPS-revision-performer screen.